Skip to main content
SEED INNOVATIONS LIMITED logo

SEED INNOVATIONS LIMITED — Investor Relations & Filings

Ticker · SEED ISIN · GB00B7VX6J75 LEI · 213800KV6ETTB1BRZ435 IL Financial and insurance activities
Open in API
Filings indexed 467 across all filing types
Latest filing 2019-07-11 Regulatory Filings
Country GG Guernsey
Listing IL SEED

About SEED INNOVATIONS LIMITED

https://seedinnovations.co/

SEED INNOVATIONS LIMITED is an investment company specializing in early-stage ventures. The firm focuses on providing investors with exposure to disruptive life sciences and technology companies, with a developing strategic emphasis on high-growth sectors such as humanoid robotics and artificial intelligence (AI). The company actively manages its multi-sector portfolio, supporting the growth and success of its investee companies to generate long-term capital growth. Its model aims to make investment opportunities, often reserved for private venture capital firms, accessible to a broader investor base.

Recent filings

Filing Released Lang Actions
Disposal of interest in Intensity Therapeutics Inc
Regulatory Filings Classification · 98% confidence The document is an RNS (Regulatory News Service) announcement from FastForward Innovations Limited regarding the disposal of its interest in Intensity Therapeutics. It details a specific corporate transaction (sale of assets/shares) and explicitly mentions that it constitutes a 'Related Party Transaction' under AIM Rules. While it involves a transaction, it is a regulatory announcement of a corporate event rather than a formal M&A takeover bid document or a standalone financial report. Given the nature of the announcement as a regulatory disclosure of a business activity, it fits best under the RNS category.
2019-07-11 English
Investee Company Update: EMMAC enters new Market
Regulatory Filings Classification · 98% confidence The document is an RNS (Regulatory News Service) announcement from the London Stock Exchange. It provides an update on an investee company (EMMAC Life Sciences) regarding a new joint venture and market entry. Since it is a general regulatory announcement regarding company news that does not fit into specific categories like M&A (which usually refers to the company's own mergers) or financial reports, it is classified as a Regulatory Filing (RNS).
2019-07-09 English
Investee Company Update: Intensity Therapeutics
Regulatory Filings Classification · 100% confidence The document is an RNS (Regulatory News Service) announcement from the London Stock Exchange. It functions as a corporate update regarding an investee company (Intensity Therapeutics Inc.) and its clinical collaboration with Merck. Since it is a general regulatory announcement regarding company news that does not fit into specific categories like M&A, Earnings, or Dividends, it is classified as a Regulatory Filing (RNS).
2019-06-26 English
Investee Company Update: Offer for Yooya
Regulatory Filings Classification · 98% confidence The document is an RNS (Regulatory News Service) announcement from FastForward Innovations Limited regarding a potential acquisition of Yooya by Regent Pacific Group. It details the terms of a non-legally binding offer, the strategic rationale, and the involvement of related parties. Since this document describes a merger/acquisition proposal and its associated conditions, it falls under the M&A Activity category.
2019-05-29 English
Disposal of interest in Vemo Education Inc.
Regulatory Filings Classification · 98% confidence The document is an RNS (Regulatory News Service) announcement regarding the disposal of an interest in an investee company (Vemo Education Inc.) by FastForward Innovations Limited. It details the financial terms of the transaction and the strategic rationale. Since it is a specific corporate announcement regarding an investment exit that does not fit into categories like M&A (which usually implies a merger or acquisition of the company itself) or share buybacks, it falls under the general regulatory filing category for news announcements.
2019-05-13 English
Investee Company Update: Intensity Therapeutics
Regulatory Filings Classification · 100% confidence The document is an RNS (Regulatory News Service) announcement issued by FastForward Innovations Limited. It serves as an update regarding an investee company, Intensity Therapeutics Inc., specifically announcing that the FDA has granted Fast Track designation to one of Intensity's clinical programs. Since this is a general regulatory announcement regarding company news that does not fit into specific categories like financial reports, dividends, or board changes, it is classified as a Regulatory Filing (RNS).
2019-04-18 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.